Advocates Pharmaceutical & Healthcare

Advocates Ltd., Pharmaceutical & Healthcare is a global Programme Management and Technical Support Organisation based in Scotland, USA and Hong Kong.  Clients include universities, virtual & start-up companies, biotechs, pharmaceutical companies, healthcare organisations and investors involved in developing cures for clinical disorders on a regional basis and with a global focus.

 

Since 2002, it has been our mission to “accelerate the development pathway towards healthier, extended lives through our competence and capacity to address drug development challenges”.

 

As a testament to this, our team of scientists, project managers & technical professionals have provided `hands on’ technical support to 17 drug development programmes from discovery to our clients required endpoint, all of which have met their development objectives, whilst maintaining focus on delivery of commercial objectives & investment opportunities.

 

 

Discovery to Market Key Services include:

 

·         Grant Funding Support

·         Technical Due Diligence / Investor Support

·         Project Management

·         Discovery & Pre-Clinical Support

·         Pharmaceutical Development CMC

·         Quality Management

·         Regulatory Preparation, Submission & Liaison

·         Operational / Commercial CMC

·         Supplies / Logistics Management

·         Clinical Support

·         Medical Devices Expertise

 

Benefits to our Clients:

 

·         Proven expertise of successfully managing development programmes

·         Experienced in all compound classes, the majority of therapeutic areas and routes of administration

·         Experts in CMC (Chemistry, Manufacturing & Controls)

·         Credible relationships with national regulatory agencies

·         Trustworthy relationships with funding bodies

·         Bases in UK, USA & HK / trade in local currencies

·         We care “caring is a powerful business advantage”

 

 

If you would like to discuss any aspect of your drug development needs please email:

Angelina Fisher at:  a.fisher@advocates.ltd.uk, alternatively, please call +44 (0) 7929 671290.

Company type
Angelina Fisher
Angelina Fisher
Director of Corporate Affairs 

Datatrial Limited

Datatrial is an eClinical solutions company, providing comprehensive data management, bio-statistical and consulting services. We have our own proprietary software, nowEDC™ which has been deployed globally in Phase I to Phase III trials.  Our ethos is to collaborate with our customers to find and offer solutions that will assist in the achievement of clinical objectives.

 

Company type
Mr Lewis Baird
Mr Lewis Baird
Business Development Manager 

Ockham Oncology

Ockham provides high-quality, global clinical research and strategic development services to pharmaceutical and biotechnology companies, assisting them in the achievement of their strategic planning, technology transfer, licensing, regulatory planning and submissions, pre-clinical development, and manufacturing goals. 

Ockham also provides fully integrated clinical trials support in the areas of Clinical Operations, Data Management and Biostatistics, as well as Regulatory dossier compilations. In addition, it offers functional and specialty resourcing services to pharmaceutical, biotech and medical device companies that require Clinical Operations, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), or Good Manufacturing Practice (GMP) auditing, Data Management, Statistical Programming, Biostatistics, and Medical Writing solutions.

Website:
www.ockham.com
Company type
Ms Andrea Cotton-Berry
Global Director, Client Services 
Mr Mike Baker
Vice President 

QCTR Ltd

QCTR is the ONLY CRO to focus exclusively on clinical trials in CNS.
With its subjective assessments and often subjective diagnosis, along with lack of biomarkers and high placebo response, CNS offers unique challenges. 
QCTR have over 15 years of experience in CNS covering diseases as diverse as Alzheimer's, TBI, stroke and schizophrenia, and orphan diseases such as Huntington's and FTD.


With a worldwide network of experienced clinicans working in neurology and psychiatry, and experienced staff knowledgable in the therapeutic field, we can plan and execute cost effective clinical trials to meet your company's specific requirements.

Website:
www.qctr.co.uk
Company type
Dr Audrey Jamieson
Business Development Manager 

Quay Pharma

Quay Pharma is one of the world’s leading Contract Development and Manufacturing Organisations, or CDMOs. Based in the UK, we provide specialist services to the pharmaceutical and biotech industries built on our unique expertise in drug formulation development, analytical services and contract manufacturing.

Quay provides formulation, analytical development and clinical trials manufacturing for companies world-wide. Applying strong project management, products are quickly and cost effectively taken from pre-clinical through phase II trials. Having deep knowledge in solid dosage form development, particularly improving bioavailability of NCEs, has resulted in many clients successfully licensing products on to large pharmaceutical companies.

Company type
Mr Michael Kruidenier
Business Development Manager 
Ms Mairaedh Pedersen
Chief Executive Officer 

Selcia Ltd

Selcia Ltd is a leading provider of contract research services in drug discovery and 14C radiolabelling.

Selcia drug discovery provides integrated drug discovery services to support academics, institutions, biotech and pharma companies. Selcia assist in grant applications; execute the medicinal chemistry to deliver the best drug candidates, provide supporting project management and primary pharmacology, to ensure project success.

Selcia radiolabelling specialises in 14C GMP radiolabelling and produces 14C radiolabelled compounds for a global customer base encompassing both the life sciences and chemical industries. Applications of the radiolabelled products prepared by Selcia include: preclinical and clinical drug metabolism studies; mass balance, microdosing, research and regulatory studies; and environmental fate studies.

The purity and structure of our products are assured by our internal MHRA GLP accredited analytical department with 500MHz, 400MHz & 300MHz NMRs, mass spec and separation specialists. The group are experts in problem resolution to ensure projects meet agreed milestones.

Areas of Expertise:

  • Medicinal chemistry:  Small molecules, macrocycles, natural product chemistry
  • Disease expertise: Anti-infectives, inflammation, CNS, pain, metabolic
  • Target classes: GPCRs, ion channels, enzymes, isomerases
  • 14C Custom Radiosynthesis
  • GMP Radiolabelled API for Clinical Trials
  • GLP/GMP Analytics – GLP NMR
  • Metabolites and Impurities (Profiling and Synthesis), standards and stable labelled compounds

www.selcia.com                               contact@selcia.com

Website:
www.selcia.com
Company type
Mr Dave Roberts
Mr Dave Roberts
BD Director Radiochemistry